Estimaciones de analistas de Wall Street para Genprex, Inc. (GNPX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 1 |
| Mantener | 0 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 1 |
| Calificación media (1-5) | 1.00 |
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-12-02 | $-6160.00 | ||
| 2026-08-14 | $-9.40 | ||
| 2026-05-13 | $-14.07 | ||
| 2026-03-30 | $-25.30 | $-286.00 | +91.2% |
| 2025-11-14 | $-109.89 | $-275.00 | +60.0% |
| 2025-08-08 | $-187.00 | $-15.62 | -1097.2% |
| 2025-05-12 | $-285.71 | $-55.88 | -411.3% |
| 2025-04-01 | $-462.00 | $-18.04 | -2461.0% |
Ratios de valoración
| Precio / Valor contable | 0.10 |
| EV / EBITDA | 0.85 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | 0 | 0 | $5885 | $13070 | $22777 | $22534 | $25575 | $15004 | $6693 | 0 |
| Beneficio Bruto | 0 | 0 | -$5885 | -$13070 | -$22777 | -$22534 | -$25575 | -$15004 | -$6693 | 0 |
| I+D | $354883 | $289934 | $971427 | $2.0M | $7.3M | $9.0M | $11.5M | $17.6M | $10.5M | $9.4M |
| Generales y Administrativos | $3.8M | $3.0M | $11.4M | $8.7M | $10.6M | $11.7M | $12.3M | $13.4M | $10.6M | $6.1M |
| Gastos Operativos | $4.1M | $3.3M | $12.4M | $10.7M | $17.9M | $20.6M | $23.8M | $31.1M | $21.2M | $15.5M |
| Beneficio Operativo | -$4.1M | -$3.3M | -$12.4M | -$10.7M | -$18.0M | -$20.7M | -$23.8M | -$31.1M | -$21.2M | -$15.5M |
| EBITDA | -$4.1M | -$3.3M | -$12.3M | -$10.6M | -$17.9M | -$20.6M | -$23.7M | -$30.8M | -$21.1M | -$15.5M |
| Gastos por Intereses | 0 | $1890 | $37982 | 0 | 0 | 0 | 0 | 0 | 0 | $739935 |
| Beneficio Antes de Impuestos | -$4.1M | -$3.3M | -$12.4M | -$10.7M | -$17.9M | -$20.7M | -$23.7M | -$30.9M | -$21.1M | -$16.2M |
| Impuestos | 0 | $80 | $29184 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$4.1M | -$3.3M | -$12.4M | -$10.7M | -$17.9M | -$20.7M | -$23.7M | -$30.9M | -$21.1M | -$16.2M |
| BPA | $-16830.00 | $-12705.00 | $-39567.00 | $-29304.00 | $-22198.00 | $-19305.00 | $-21780.00 | $-24838.00 | $-5872.98 | $-382.80 |
| BPA Diluido | $-16786.00 | $-12683.00 | $-39534.00 | $-29249.00 | $-22198.00 | $-19305.00 | $-21780.00 | $-24816.00 | $-5872.98 | $-382.80 |
| Acciones en Circulación (Diluidas) | $246 | $261 | $313 | $364 | $807 | $1070 | $1090 | $1243 | $3642 | $42397 |
Precio
| Precio | $3.41 |
| Capitalización | $2M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: BDRX · BIVI · CERO · CMMB · CNSP · GRI · INM
Explorar sector: Healthcare · Biotechnology
Más secciones de GNPX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones